全文获取类型
收费全文 | 9806篇 |
免费 | 578篇 |
国内免费 | 75篇 |
专业分类
耳鼻咽喉 | 153篇 |
儿科学 | 244篇 |
妇产科学 | 125篇 |
基础医学 | 1647篇 |
口腔科学 | 219篇 |
临床医学 | 696篇 |
内科学 | 2252篇 |
皮肤病学 | 287篇 |
神经病学 | 632篇 |
特种医学 | 328篇 |
外科学 | 1302篇 |
综合类 | 27篇 |
预防医学 | 368篇 |
眼科学 | 404篇 |
药学 | 733篇 |
中国医学 | 24篇 |
肿瘤学 | 1018篇 |
出版年
2023年 | 71篇 |
2022年 | 152篇 |
2021年 | 248篇 |
2020年 | 108篇 |
2019年 | 146篇 |
2018年 | 228篇 |
2017年 | 188篇 |
2016年 | 222篇 |
2015年 | 231篇 |
2014年 | 328篇 |
2013年 | 353篇 |
2012年 | 520篇 |
2011年 | 640篇 |
2010年 | 384篇 |
2009年 | 304篇 |
2008年 | 564篇 |
2007年 | 618篇 |
2006年 | 588篇 |
2005年 | 631篇 |
2004年 | 541篇 |
2003年 | 509篇 |
2002年 | 530篇 |
2001年 | 253篇 |
2000年 | 195篇 |
1999年 | 208篇 |
1998年 | 118篇 |
1997年 | 102篇 |
1996年 | 106篇 |
1995年 | 67篇 |
1994年 | 79篇 |
1993年 | 58篇 |
1992年 | 135篇 |
1991年 | 121篇 |
1990年 | 90篇 |
1989年 | 100篇 |
1988年 | 76篇 |
1987年 | 86篇 |
1986年 | 87篇 |
1985年 | 62篇 |
1984年 | 59篇 |
1983年 | 44篇 |
1982年 | 22篇 |
1981年 | 24篇 |
1980年 | 21篇 |
1979年 | 44篇 |
1978年 | 16篇 |
1977年 | 31篇 |
1976年 | 23篇 |
1968年 | 26篇 |
1967年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 9 毫秒
1.
Chie Teramoto PHN RN MS Satoko Nagata PhD PHN RN Reiko Okamoto PhD PHN RN Ruriko Suzuki PHN RN MS Emiko Kishi PhD PHN RN Michie Nomura DSN PHN RN Noriko Jojima PHN RN MS Masumi Nishida PhD PHN RN Keiko Koide PhD PHN RN Emiko Kusano PhD PHN RN Saori Iwamoto PhD PHN RN Sachiyo Murashima PhD PHN RN 《Public health nursing (Boston, Mass.)》2015,32(6):654-661
2.
3.
Nagai Masahiro Nishikawa Noriko Yabe Hayato Moritoyo Hiroyoko Moritoyo Takashi Shigematsu Yuji Nomoto Masahiro 《Journal of neurology》2007,254(4):IV54-IV57
Journal of Neurology - A high incidence of valvular heart disease in Parkinson's disease (PD) patients treated with ergot-derived dopamine agonists, such as cabergoline and pergolide, has been... 相似文献
4.
5.
Permanent prostate brachytherapy for Japanese men: Results from initial 100 patients with prostate cancer 总被引:1,自引:1,他引:0
Toshikazu Okaneya Shuji Nishizawa Tsuyoshi Nakayama Takayuki Kamigaito Iwao Hashida Noriko Hosaka 《International journal of urology》2007,14(7):602-606
OBJECTIVE: To evaluate the initial results of brachytherapy for prostate cancer with permanent iodine-125 implant in Japan. METHODS: The results obtained with brachytherapy in the initial 100 Japanese patients treated at Nagano Municipal Hospital were reviewed. Patients with a prostate-specific antigen (PSA) level of less than 10 ng/mL and a Gleason's scores of 5, 6, 3 + 4 were classified as having a low risk of recurrence. Patients with a PSA level of 10-20 ng/mL and/or a Gleason's score of 4 + 3 were classified as having an intermediate risk for recurrence. Seventy-eight of the low-risk patients and 19 of the intermediate-risk patients were treated by seed implants alone, or seed implants combined with preceding external radiation, respectively. A total of 53 patients received neoadjuvant hormone therapy. The efficacy and morbidity of brachytherapy were investigated using the serum PSA, International Prostate Symptom Score, quality of life score and uroflowmetry data. RESULTS: The average V100 and D90 obtained by post-implant dosimetry was 94.3 and 113.7%, respectively. Serum PSA decreased gradually after treatment, although it had still not reached a nadir after 1 year. There was little difference of the PSA level between the patients with and without neoadjuvant hormone therapy even at 1 year after seed implantation. There were no PSA biochemical failure or clinical recurrence during the follow-up period. Voiding symptoms worsened until 3 months after treatment, and then gradually improved. Acute urinary retention occurred transiently in one patient (1%). Rectal bleeding and severe diarrhea did not occur. CONCLUSION: Brachytherapy is a feasible and effective option for the treatment of prostate cancer in Japanese men. Brachytherapy may have a different effect in Japanese patients with respect to voiding symptoms. Urinary retention was rare, but voiding symptoms were persistent in Japanese patients. Neoadjuvant hormone therapy deserves investigation to determine whether it can achieve better results, especially in patients with an intermediate risk. 相似文献
6.
7.
8.
K Yamauchi K Ohashi H Osanai N Inagaki S Yamaguchi H Hashimoto S Yachiku 《Hinyokika kiyo. Acta urologica Japonica》1990,36(12):1485-1490
The effects and the safety of oxybutynin hydrochloride were investigated in 52 patients, 17 male and 35 female, with the chief complaints of pollakisuria, urgency and urinary incontinence. Clinical responses to the drug were assessed mainly by the subjective symptoms of the patients. The diagnoses of these patients were neurogenic bladder in 17, unstable bladder in 16 and others in 19 patients. The average administration period was 66.8 days. The rate of global improvement (excellent and good) was 55% in the 2 mg dose given 3 times daily group, 68.2% in the 3 mg dose given 3 times daily group. Side effects, such as dry mouth, were observed in 2 of the 52 patients (3.8%), but no serious side effects were observed. The rate of global utility (remarkable and moderate) was 67.3%. These data indicate that oxybutynin hydrochloride seems to be useful and safe for the treatment of pollakisuria, urgency and urinary incontinence. 相似文献
9.
10.
T Ohashi F Yamamoto H Yamamoto H Ichikawa T Shibata Y Shimada T Ishikawa K Kagisaki Y Kumada Y Kawashima 《[Zasshi] [Journal]. Nihon Kyōbu Geka Gakkai》1992,40(11):1998-2004
The effects of potassium in reperfusion solution (RS) and the influence of sodium on this effect were studied. Experimental time course was as followed: 20 min working perfusion, 3 min cardioplegic infusion with St. Thomas Cardioplegic Solution followed by global ischemia for 33 or 35 min at 37.5 degrees C, 15 min early Langendorff reperfusion with several different potassium concentration modified with Krebs Henseleit Bicarbonate Buffer (KHBB) containing 145 mM and 110 mM sodium and 5 min late reperfusion with KHBB, followed by 20 min working perfusion. Potassium in RS possessed bell shaped dose response nature with optimal concentration of 10 mM in the condition of 145 mM sodium but 6 m in the condition of 110 mM in terms of percent recovery of aortic flow. Although higher potassium reperfusion produced less Creatine Kinase leakage. 相似文献